Cynthia Caracta

Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

Zarir Udwadia, Pawan Singh, Hanmant Barkate et al. · International Journal of Infectious Diseases · 2020 · 291 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study

Paul Jones, Dave Singh, Eric Bateman et al. · European Respiratory Journal · 2012 · 184 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study

Dave Singh, Paul Jones, Eric Bateman et al. · BMC Pulmonary Medicine · 2014 · 174 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study

Anthony D’Urzo, Stephen I. Rennard, Edward Kerwin et al. · Respiratory Research · 2014 · 147 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I)

Edward Kerwin, Anthony D’Urzo, Arthur F. Gelb et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2012 · 133 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16